Therefore, it is feasible to use either LncRNA UCA1 si treatment and/or ROCK inhibitor to limit tumor cell migration and invasion (Table 2) and to reduce HA/CD44-induced tumor metastasis and progression. Here, UCA1 is linked to neoplasm.